Endothelial markers in schistosomiasis patients with or without portal hypertension

Digestive Diseases and Sciences

Volumn 54, Issue 6, 2009, Pages 1331-1336

  De Toledo, Carlos Fischer ^a   Carvente, Claudia Teresa ^a   Shigueoka, David Carlos ^a   Borges, Durval Rosa ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Endothelial markers; Endothelin 1; Endothelin 3; Portal hypertension; Schistosomiasis mansoni; Vascular endothelial growth factor; Von Willebrand factor

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ENDOTHELIN 1; ENDOTHELIN 3; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; SERUM ALBUMIN; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; LIVER CIRRHOSIS; MALE; PH; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; SCHISTOSOMIASIS; SCHISTOSOMIASIS MANSONI; SPLEEN SIZE; SPLENIC VEIN; THROMBOCYTE COUNT; VEIN DIAMETER;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION, PORTAL; LIVER; MALE; MIDDLE AGED; SCHISTOSOMIASIS MANSONI; YOUNG ADULT;

EID: 67349133772     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0475-8     Document Type: Article

References (27)

1. DCP Vezozzo AQ Farias GG Cerri LC Da Silva FJ Carrilho 2006 Assessment of portal hemodynamics by Doppler ultrasound and of liver morphology in the hepatosplenic and hepatointestinal forms of Schistosomiasis mansoni Dig Dis Sci 51 1413 1419 10.1007/s10620-005-9020-1 (Pubitemid 44315810)
2. L Camacho-Lobato DR Borges 1996 Plasma proteins of hemostasis in the hepatintestinal form of Schistosomiasis mansoni Clin Appl Thromb Hemost 2 276 278 10.1177/107602969600200408 (Pubitemid 126699616)
3. DR Borges N Manoukian CF Toledo 1987 Protein C deficiency in the compensated form of hepatosplenic schistosomiasis Braz J Med Biol Res 20 557 560
4. N Manoukian DR Borges 1988 Hypoprothrombinemia in the compensated form of hepatosplenic schistosomiasis: further studies Rev Inst Med Trop Sao Paulo 30 274 280
5. L Camacho-Lobato DR Borges 1998 Early liver dysfunction in schistosomiaisis J Hepatol 29 233 240 10.1016/S0168-8278(98)80008-1 (Pubitemid 28352808)
6. MRA Souza CF Toledo DR Borges 2000 Thrombocytemia as a predictor of portal hypertension in schistosomiasis Dig Dis Sci 45 1964 1970 10.1023/A:1005535808464
7. MRA Souza LA Köpke-Aguiar JM Goto CT Carvente CF Toledo DR Borges 2002 Thrombopoietin serum levels do not correlate with thrombocytopenia in hepatic schistosomiasis Liver 22 127 129 10.1034/j.1600-0676.2002.01574.x (Pubitemid 34591253)
8. PJ Ribeiro JL Narciso CF Toledo DR Borges 2005 γ- Glutamyltransferase decreases in patients with the chronic form Schistosomiasis mansoni treated with ursodeoxycholic acid J Clin Pathol 58 783 784 (Pubitemid 40956841)
9. RD Martins DR Borges 1993 Ethanol challenge in non-alcoholic patients with schistosomiasis J Clin Pathol 46 250 253 10.1136/jcp. 46.3.250 (Pubitemid 23098626)
10. LA Kopke-Aguiar JRM Martins CC Passerotti CF Toledo HB Nader DR Borges 2002 Serum hyaluronic acid as a comprehensive marker to asses severity of liver disease in schistosomiaisis Acta Trop 84 117 126 10.1016/S0001-706X(02)00136-5 (Pubitemid 35335762)
11. AL Rabello 1992 Parasitological diagnosis of Schistosomiasis mansoni: fecal examination and rectal biopsy Mem Inst Oswaldo Cruz 87 Suppl 4 325 331
12. M Kamper-Jorgensen M Gronbaeck J Tolstrup U Becker 2004 Alchohol and cirrhosis: dose-response or threshold effect? J Hepatol 41 25 30 10.1016/j.jhep. 2004.03.002 (Pubitemid 39005148)
13. Report WHO. Ultrasound in schistosomiasis. A practical guide to the standardized use of ultrasonography for the assessment of schistosomiasis- related morbidity (2000) Report of a WHO Expert Committee. Geneva, World Health Organization, (Report TDR/STR/SCH/00.1).
14. MH Zweig G Campbell 1993 Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine Clin Chem 39 561 577 (Pubitemid 23118304)
15. F Akiyoshi M Sata H Suzuki 1998 Serum vascular endothelial growth factor levels in various liver diseases Dig Dis Sci 43 41 45 10.1023/A:1018863718430 (Pubitemid 28081640)
16. N Assy M Paizi D Gaitini Y Baruch G Spira 1999 Clinical implication of VEGF serum levels in cirrhotic patients with or without portal hypertension World J Gastroenterol 5 296 300
17. J Genesca A Gonzalez A Mujal F Cereto R Segura 1999 Vascular endothelial growth factor levels in liver cirrhosis Dig Dis Sci 44 1261 1262 10.1023/A:1026618904493 (Pubitemid 29297239)
18. B Shi X Wang Z Yang 2001 Vascular endothelial growth factors and liver diseases Hepatogastroenterology 48 1145 1148 (Pubitemid 32761706)
19. GM Tawfeek AM Alafifi MF Azmy 2003 Immunological indicators of morbidity in human Schistosomiasis mansoni: role of vascular endothelial growth factor and anti-soluble egg antigen IgG4 in disease progression J Egypt Soc Parasitol 33 597 614
20. DA Loeffler SK Lundy KP Singh HC Gerard AP Hudson DL Boros 2002 Soluble egg antigens from Schistosoma mansoni induce angiogenesis-related processes by up-regulating vascular endothelial growth factor in human endothelial cells J Infect Dis 185 1650 1656 10.1086/340416 (Pubitemid 34587528)
21. D Ferro C Quintarelli A Lattuada R Leo M Alessandroni PM Mannucci 1996 High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia Hepatology 23 1377 1383 10.1002/hep. 510230613 (Pubitemid 26181219)
22. L Albornoz D Alvarez JC Otaso 1999 Von Willebrand factor could be an index of endothelial dysfunction in patients with cirrhosis relationship to degree of liver failure and nitric oxide levels J Hepatol 30 451 455 10.1016/S0168-8278(99)80104-4 (Pubitemid 29113234)
23. DC Rockey 2000 Vasoactive agents in intrahepatic portal hypertension and fibrogenesis: implications for therapy Gastroenterology 118 1261 1265 10.1016/S0016-5085(00)70379-9 (Pubitemid 30347002)
24. J Reichen 1999 Portal hypertension: cytokines and endothelin Hepatogastroenterol 46 1434 1436
25. DC Rockey 2003 Vascular mediators in the injured liver Hepatology 37 4 12 10.1053/jhep. 2003.50044 (Pubitemid 36042137)
26. AL Gerbes V Gulberg M Bilzer 1998 Endothelin and other mediators in the pathophysiology of portal hypertension Digestion 59 Suppl 2 8 10 10.1159/000051412 (Pubitemid 28372161)
27. A Mallat 1998 Hepatic stellate cells and intrahepatic modulation of portal pressure Digestion 59 416 419 10.1159/000007501 (Pubitemid 28360705)